Cadila falls on earnings, broker downgrades
MUMBAI (Reuters) - Cadila Healthcare (CADI.NS) shares fell as much as 8.9 percent after October-December earnings disappointed on Friday, followed by broker downgrades.
Cadila said its December quarter net profit fell by 30.9 percent to 1.03 billion rupees.
Credit Suisse downgraded the stock to "neutral" from "outperform", citing delay in contribution from higher margin products.
(Reporting by Abhishek Vishnoi; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
- Citi to hire 100 bankers in Asia, eyes more business from smaller clients
- West agrees wider Russia sanctions as Kiev says forces near crash site
- Cricket - Moeen probed after sporting 'Save Gaza' wristbands
- Israel warns of long Gaza war as Palestinian fighters cross border
- Israel extends Gaza ceasefire for 24 hours, Hamas rejects terms
India's largest cigarette maker ITC Ltd on Tuesday said first-quarter net profit grew 16 percent, lagging forecasts although sales beat market expectations. Full Article
With PlayStation network, Sony goes back to the future in search of revival Full Article